Table 1.
Characteristics | Type of intervention |
p | |
---|---|---|---|
Maintain antimicrobial |
Antimicrobial withholding |
||
n = 92 | n = 84 | ||
Age in years, median (IQR) | 5 (3–9) | 4 (3–8) | 0.57 |
Male gender, n (%) | 40 (44) | 46 (55) | 0.13 |
Type of cancer, n (%) | |||
Leukaemia/Lymphoma | 49 (53) | 55 (66) | 0.09 |
Leukaemia relapse | 7 (8) | 4 (5) | 0.43 |
Solid tumours | 36 (39) | 25 (29) | 0.19 |
High risk for invasive bacterial infection, n (%) | 43 (47) | 45 (54) | 0.36 |
Use of G-CSF, n (%) | 27 (29) | 26 (31) | 0.81 |
Use of CVC, n (%) | 77 (84) | 68 (81) | 0.63 |
Hours of fever previous to admission, median (IQR) | 2 (1–4) | 2 (1–3) | 0.10 |
Admission clinical diagnosis, n (% ) | |||
Fever without focus | 19 (20) | 13 (16) | 0.37 |
Upper respiratory infection | 42 (46) | 44 (52) | 0.37 |
Lower respiratory infection | 23 (25) | 22 (26) | 0.85 |
Intestinal focus | 6 (7) | 5 (6) | 0.87 |
Othersa | 2 (2) | 0 |
G-CSF: granulocyte-colony stimulating factor; CVC: central venous catheter; IQR: Interquartile range
Others: Skin/soft tissue infection